356
Participants
Start Date
February 1, 2021
Primary Completion Date
September 25, 2021
Study Completion Date
September 25, 2021
K-877 ER 0.2 mg/day (once daily)
K-877 ER 0.2 mg tablet
K-877 ER 0.4 mg/day (once daily)
K-877 ER 0.4 mg tablet
K-877 IR 0.2 mg/day (twice daily)
K-877 IR 0.1 mg tablet
Institute Medical Corporation Hitomikai Motomachi Takatsuka Naika Clinic, Kanagawa
Medical Corporation Heishinkai OCROM Clinic, Osaka
Dojinkinenkai Meiwa Hospital, Tokyo
Fukuwa Clinic, Tokyo
Ikebukuro Metropolitan Clinic, Tokyo
Medical Corp. Seikoukai New Medical Research System Clinic, Tokyo
Medical Corporation Asbo Tokyo Asbo Clinic, Tokyo
Medical Corporation Chiseikai Tokyo Center Clinic, Tokyo
Medical Corporation Heishinkai ToCROM Clinic, Tokyo
Medical Corporation Yuhokai Miho Clinic, Tokyo
Tokyo-Eki Center-building Clinic, Tokyo
Kowa Company, Ltd.
INDUSTRY